Open AccessThe effect of pre‐existing mental health comorbidities on the stage at diagnosis and timeliness of care of solid tumor malignances in a Veterans Affairs ( VA ) medical center
Author(s) -
Wadia Roxanne J.,
Yao Xiaopan,
Deng Yanhong,
Li Jia,
Maron Steven,
Connery Donna,
GunduzBruce Handan,
Rose Michal G.
Publication year - 2015
Publication title -
cancer medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.403
H-Index - 53
ISSN - 2045-7634
DOI - 10.1002/cam4.483
Subject(s) - veterans affairs , medicine , stage (stratigraphy) , mental health , medical record , colorectal cancer , health care , comorbidity , cancer , retrospective cohort study , oncology , psychiatry , paleontology , economics , biology , economic growth
There are limited data on the impact of mental health comorbidities ( MHC ) on stage at diagnosis and timeliness of cancer care. Axis I MHC affect approximately 30% of Veterans receiving care within the Veterans Affairs ( VA ) system. The purpose of this study was to compare stage at diagnosis and timeliness of care of solid tumor malignancies among Veterans with and without MHC . We performed a retrospective analysis of 408 charts of Veterans with colorectal, urothelial, and head/neck cancer diagnosed and treated at VA Connecticut Health Care System ( VACHS ) between 2008 and 2011. We collected demographic data, stage at diagnosis, medical and mental health co‐morbidities, treatments received, key time intervals, and number of appointments missed. The study was powered to assess for stage migration of 15–20% from Stage I/II to Stage III / IV . There was no significant change in stage distribution for patients with and without MHC in the entire study group ( p = 0.9442) and in each individual tumor type. There were no significant differences in the time intervals from onset of symptoms to initiation of treatment between patients with and without MHC ( p = 0.1135, 0.2042 and 0.2352, respectively). We conclude that at VACHS , stage at diagnosis for patients with colorectal, urothelial and head and neck cancers did not differ significantly between patients with and without MHC . Patients with MHC did not experience significant delays in care. Our study indicates that in a medical system in which mental health is integrated into routine care, patients with Axis I MHC do not experience delays in cancer care.